CHICAGO, May 15, 2025 -- (BUSINESS WIRE)--MAIA Biotechnology, Inc. (NYSE American: MAIA), a clinical-stage biopharmaceutical company focused on developing targeted immunotherapies for cancer, today ...

TScan Therapeutics announced an accepted abstract for poster presentation at ASGCT's annual meeting on TCR-engineered therapies for cancer.

SAN DIEGO, April 24, 2025 (GLOBE NEWSWIRE) -- BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody ...

SAN DIEGO, April 23, 2025 (GLOBE NEWSWIRE) -- Zentalis ® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company developing a potentially first-in-class and best-in-class WEE1 ...

SAN DIEGO, April 23, 2025 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company developing a potentially first-in-class and best-in-class ...

Student Poster Templates The links below invite you to make a copy of the file. This gives you the change to make the template your own. Traditional Poster Template #BetterPoster Template Empty Poster ...

Poster Templates The SOPH Office of Research has developed poster templates for the school’s use. We strongly encourage poster presenters to use these templates. Templates are available for download.

Engaging students through poster presentations: a case study Read about how a poster presentation task can promote students’ engagement with course content and each other ...

Google Slides is getting a refreshed collection of professionally designed templates this week, including options for business or school presentations.

If you choose to use the poster template, you can change the width of the three panels somewhat but should refrain from filling the panels with too much text. You can also customize the background ...

The second abstract accepted for poster presentation contains new pre-clinical data for the next candidate in the IO Biotech pipeline, IO112, which targets Arginase 1.

NEW YORK, Oct. 04, 2024 (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, off-the-shelf, immune-modulating therapeutic cancer vaccines based ...